Cureus Takes a Stand Against Unchecked Use of Human-Author Research by AI

Cureus, a medical publishing platform, is pushing back against the use of its open-access content by artificial intelligence systems. In an effort to preserve the intellectual integrity of its articles, Cureus has updated its terms of use to prohibit the use of its site content for AI training, data mining, and creating derivative works. This move reflects the platform's commitment to authorship as a human right, ensuring that real knowledge is generated and shared by humans. Cureus co-founder and co-editor-in-chief, Professor John Adler, emphasizes that the platform is not anti-technology, but rather pro-human, committed to amplifying authentic scientific voices.

Key Takeaways:

• Cureus has updated its terms of use to explicitly prohibit the use of its site content by artificial intelligence systems for training, data mining, and creating derivative works.
• The platform believes authorship is a human right and is committed to preserving the originality and intellectual integrity of every article published.
• Cureus is not anti-technology, but rather pro-human, committed to amplifying authentic scientific voices in an age where machines can replicate text.
• The platform's updated terms of use reflect its values and commitment to human authorship.

Statistics:

• Over 25,000 articles were published on Cureus in 2024.
• The platform has 6.3 million monthly article views.
• Cureus is indexed in PubMed Central, Google Scholar, Dimensions, and more.
• The platform has a 52% acceptance rate for articles submitted.

Sources:

• Cureus Inc.